Fny Investment Advisers, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History
Fny Investment Advisers, LLC
- $237 Million
- Q2 2025
A detailed history of Fny Investment Advisers, LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 2,300 shares of BHVN stock, worth $33,810. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,300
Previous 800
187.5%
Holding current value
$33,810
Previous $19,000
68.42%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding BHVN
# of Institutions
10Shares Held
965KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL895KShares$13.2 Million8.59% of portfolio
-
Eaton Vance Management Boston, MA35.9KShares$527,8470.01% of portfolio
-
S. Muoio & Co. LLC New York, NY19KShares$279,0063.79% of portfolio
-
Agf Investments LLC Boston, MA11.6KShares$169,9320.16% of portfolio
-
Surevest, LLC Los Angeles, CA751Shares$11,0390.03% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $1.05B
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...